Tumor Marker:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Leise Präambel Vulkanisch туморни маркери ca 19 9 Sparen Schäbig Tansania
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
CA19-9 - Wikipedia
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA | BMC Medicine | Full Text
Cancers | Free Full-Text | Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer
Table 1 from Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
CA19-9 - Wikipedia
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies | bioRxiv
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
